{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:32:14Z","timestamp":1789824734286,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00467-011-1870-5","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T23:41:14Z","timestamp":1302306074000},"page":"1105-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Ekaterini","family":"Siomou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Printza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Giapros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Petropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Mitsioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos J.","family":"Stefanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"IB Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975\u2013982","journal-title":"Kidney Int"},{"key":"1870_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"IB Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int 45:253\u2013258","journal-title":"Kidney Int"},{"key":"1870_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1651-2227.2000.tb00361.x","volume":"89","author":"H Zi\u00f3lkowska","year":"2000","unstructured":"Zi\u00f3lkowska H, Pa\u0144czyk-Tomaszewska M, D\u0119bi\u0144ski A, Polowiec Z, Sawicki A, Sieniawska M (2000) Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 89:666\u2013671","journal-title":"Acta Paediatr"},{"key":"1870_CR5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, J\u00fcppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205\u20132215","journal-title":"J Am Soc Nephrol"},{"key":"1870_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, L\u00fcthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"1870_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.192.4.463","volume":"192","author":"H Min","year":"2000","unstructured":"Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192:463\u2013474","journal-title":"J Exp Med"},{"key":"1870_CR8","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a lignad for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"1870_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.bone.2009.06.011","volume":"45","author":"X Li","year":"2009","unstructured":"Li X, Ominsky MS, Stolina M, Warmington KS, Geng Z, Niu QT, Asuncion FJ, Tan HL, Grisanti M, Dwyer D, Adamu S, Ke HZ, Simonet WS, Kostenuik PJ (2009) Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor ostoprotegerin. Bone 45:669\u2013676","journal-title":"Bone"},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1359\/JBMR.0301226","volume":"19","author":"JC Huang","year":"2004","unstructured":"Huang JC, Sakata T, Pfieger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA (2004) PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235\u2013244","journal-title":"J Bone Miner Res"},{"key":"1870_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","volume":"17","author":"G Coen","year":"2002","unstructured":"Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, Jankovic L, Manni M, Morosetti M, Moscaritolo E, Sardella D, Bonucci E (2002) Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 17:233\u2013238","journal-title":"Nephrol Dial Transplant"},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1515\/CCLM.2007.306","volume":"45","author":"M Shaarawy","year":"2007","unstructured":"Shaarawy M, Fathy SA, Mehany NL, Hindy OW (2007) Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure. Clin Chem Lab Med 45:1498\u20131503","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl 3","key":"1870_CR13","first-page":"68","volume":"63","author":"H Zi\u00f3lkowska","year":"2006","unstructured":"Zi\u00f3lkowska H, Roszkowska-Blaim M (2006) Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure. Przegl Lek 63[Suppl 3]:68\u201371","journal-title":"Przegl Lek"},{"key":"1870_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00467-006-0231-2","volume":"21","author":"D Swolin-Eide","year":"2006","unstructured":"Swolin-Eide D, Hansson S, Larsson L, Magnusson P (2006) The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 21:1723\u20131729","journal-title":"Pediatr Nephrol"},{"key":"1870_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1651-2227.2007.00236.x","volume":"96","author":"D Swolin-Eide","year":"2007","unstructured":"Swolin-Eide D, Magnusson P, Hansson S (2007) Bone mass, biochemical markers and growth in children with chronic kidney disease: a 1-year prospective study. Acta Paediatr 96:720\u2013725","journal-title":"Acta Paediatr"},{"key":"1870_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1651-2227.2008.01073.x","volume":"98","author":"D Swolin-Eide","year":"2009","unstructured":"Swolin-Eide D, Hansson S, Magnusson P (2009) Children with chronic kidney disease: a 3-year prospective study of growth, bone mass and bone turnover. Acta Paediatr 98:367\u2013373","journal-title":"Acta Paediatr"},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1093\/ndt\/gfn226","volume":"23","author":"RC Shroff","year":"2008","unstructured":"Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263\u20133271","journal-title":"Nephrol Dial Transplant"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"c153","DOI":"10.1159\/000099005","volume":"105","author":"O Ozkaya","year":"2007","unstructured":"Ozkaya O, Buyan N, Bideci A, Gonen S, Ortac E, Fidan K, Cinaz P, S\u00f6ylemezo\u011flu O (2007) Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis. Nephron Clin Pract 105:c153\u2013c158","journal-title":"Nephron Clin Pract"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5414\/CNP70306","volume":"70","author":"S Kagami","year":"2008","unstructured":"Kagami S, Ohkido I, Yokoyama K, Shigematsu T, Hosoya T (2008) Osteoprotegerin affects the responsiveness of fibroblast growth factor-23 to high oral phosphate intake. Clin Nephrol 70:306\u2013311","journal-title":"Clin Nephrol"},{"issue":"4 Suppl 1","key":"1870_CR20","first-page":"S1","volume":"46","author":"Kidney Disease Outcomes Quality Initiative","year":"2005","unstructured":"Kidney Disease Outcomes Quality Initiative, National Kidney Foundation (2005) K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46[4 Suppl 1]:S1\u2013S121","journal-title":"Am J Kidney Dis"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"1870_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, R\u00f6nnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schr\u00f6der C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159","journal-title":"Pediatr Nephrol"},{"key":"1870_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00467-009-1384-6","volume":"25","author":"K Wesseling-Perry","year":"2010","unstructured":"Wesseling-Perry K (2010) FGF-23 in bone biology. Pediatr Nephrol 25:603\u2013608","journal-title":"Pediatr Nephrol"},{"key":"1870_CR24","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/ndt\/17.10.1860","volume":"17","author":"JJ Kazama","year":"2002","unstructured":"Kazama JJ, Kato H, Sato T, Shigematsu T, Fukagawa M, Iwasaki Y, Gejyo F (2002) Circulating osteoprotegerin is not removed through haemodialysis membrane. Nephrol Dial Transplant 17:1860\u20131861","journal-title":"Nephrol Dial Transplant"},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clinbiochem.2006.01.020","volume":"39","author":"E Wittersheim","year":"2006","unstructured":"Wittersheim E, Mesquita M, Demulder A, Guns M, Louis O, Melot C, Dratwa M, Bergmann P (2006) OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clin Biochem 39:617\u2013622","journal-title":"Clin Biochem"},{"key":"1870_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00467-007-0671-3","volume":"23","author":"K Wesseling","year":"2008","unstructured":"Wesseling K, Bakkalogly S, Salusky I (2008) Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol 23:195\u2013207","journal-title":"Pediatr Nephrol"},{"key":"1870_CR27","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1210\/jc.2005-0794","volume":"90","author":"A Rogers","year":"2005","unstructured":"Rogers A, Eastell R (2005) Review: Circulating osteoprotegerin and receptor activator for nuclear factor \u03baB ligand: Clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323\u20136331","journal-title":"J Clin Endocrinol Metab"},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00467-009-1260-4","volume":"25","author":"M Kuro-o","year":"2010","unstructured":"Kuro-o M (2010) Overview of the FGF23-Klotho axis. Pediatr Nephrol 25:583\u2013590","journal-title":"Pediatr Nephrol"},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00467-009-1273-z","volume":"25","author":"J Gattineni","year":"2010","unstructured":"Gattineni J, Baum M (2010) Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr Nephrol 25:591\u2013601","journal-title":"Pediatr Nephrol"},{"key":"1870_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bj\u00f6rklund P, Marsell R, Ljunggren O, Akerstr\u00f6m G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125\u2013131","journal-title":"J Endocrinol"},{"key":"1870_CR31","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008","journal-title":"J Clin Invest"},{"key":"1870_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78:975\u2013980","journal-title":"Kidney Int"},{"key":"1870_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/00365510903359245","volume":"70","author":"P Magnusson","year":"2010","unstructured":"Magnusson P, Hansson S, Swolin-Eide D (2010) A prospective study of fibroblast growth factor-23 in children with chronic kidney disease. Scand J Clin Lab Invest 70:15\u201320","journal-title":"Scand J Clin Lab Invest"},{"key":"1870_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/jc.2008-0326","volume":"94","author":"K Wesseling-Perry","year":"2009","unstructured":"Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, J\u00fcppner H, Salusky IB (2009) Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511\u2013517","journal-title":"J Clin Endocrinol Metab"},{"key":"1870_CR35","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"P Ure\u00f1a","year":"1999","unstructured":"Ure\u00f1a P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141\u20132156","journal-title":"Kidney Int"},{"key":"1870_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","volume":"82","author":"K Shidara","year":"2008","unstructured":"Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y (2008) Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 82:278\u2013287","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 114","key":"1870_CR37","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/ki.2009.405","volume":"76","author":"S Seiler","year":"2009","unstructured":"Seiler S, Heine GH, Fliser D (2009) Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int 76[Suppl 114]:S34\u2013S42","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-011-1870-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1870-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T17:32:16Z","timestamp":1610818336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-011-1870-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1007\/s00467-011-1870-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"6 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}